Predicting Grade of Cerebral Glioma Using Vascular-Space Occupancy MR Imaging

References

1. ↵
   Jackson RJ, Fuller GN, Abi-Said D, et al. Limitations of stereotactic biopsy in the initial management of gliomas. Neuro-oncol 2001;3:193–200

   Abstract/FREE Full Text
2. Daumas-Duport C, Scheithauer B, O'Fallon J, et al. Grading of astrocytomas. A simple and reproducible method. Cancer 1988;62:2152–65

   CrossRefPubMedWeb of Science
3. Coons SW, Johnson PC, Scheithauer BW, et al. Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas. Cancer 1997;79:1381–93

   CrossRefPubMedWeb of Science
4. Sawaya R. Extent of resection in malignant gliomas: a critical summary. J Neurooncol 1999;42:303–05

   CrossRefPubMed
5. Gilles FH, Brown WD, Leviton A, et al. Limitations of the World Health Organization classification of childhood supratentorial astrocytic tumors. Children Brain Tumor Consortium. Cancer 2000;88:1477–83

   CrossRefPubMedWeb of Science
6. ↵
   Shaw EG, Wisoff JH. Prospective clinical trials of intracranial low-grade glioma in adults and children. Neuro-oncol 2003;5:153–60

   Abstract/FREE Full Text
7. ↵
   Barker FG 2nd, Chang SM, Huhn SL, et al. Age and the risk of anaplasia in magnetic resonance-nonenhancing supratentorial cerebral tumors. Cancer 1997;80:936–41

   CrossRefPubMedWeb of Science
8. ↵
   Scott JN, Brasher PM, Sevick RJ, et al. How often are nonenhancing supratentorial gliomas malignant? A population study. Neurology 2002;59:947–49

   Abstract/FREE Full Text
9. ↵
   Aronen HJ, Gazit IE, Louis DN, et al. Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 1994;191:41–51

   PubMedWeb of Science
10. Sugahara T, Korogi Y, Kochi M, et al. Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas. AJR Am J Roentgenol 1998;171:1479–86

    CrossRefPubMedWeb of Science
11. ↵
    Knopp EA, Cha S, Johnson G, et al. Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging. Radiology 1999;211:791–98

    CrossRefPubMedWeb of Science
12. ↵
    Law M, Yang S, Wang H, et al. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. AJNR Am J Neuroradiol 2003;24:1989–98

    Abstract/FREE Full Text
13. ↵
    Law M, Yang S, Babb JS, et al. Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. AJNR Am J Neuroradiol 2004;25:746–55

    Abstract/FREE Full Text
14. ↵
    Law M, Oh S, Babb JS, et al. Low-grade gliomas: dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging–prediction of patient clinical response. Radiology 2006;238:658–67

    CrossRefPubMedWeb of Science
15. ↵
    Rausch M, Scheffler K, Rudin M, et al. Analysis of input functions from different arterial branches with gamma variate functions and cluster analysis for quantitative blood volume measurements. Magn Reson Imaging 2000;18:1235–43

    CrossRefPubMed
16. ↵
    Calamante F, Morup M, Hansen LK. Defining a local arterial input function for perfusion MRI using independent component analysis. Magn Reson Med 2004;52:789–97

    CrossRefPubMed
17. ↵
    Schmitt M, Viallon M, Thelen M, et al. Quantification of myocardial blood flow and blood flow reserve in the presence of arterial dispersion: a simulation study. Magn Reson Med 2002;47:787–93

    CrossRefPubMed
18. ↵
    Lu H, Law M, Johnson G, et al. Novel approach to the measurement of absolute cerebral blood volume using vascular-space-occupancy magnetic resonance imaging. Magn Reson Med 2005;54:1403–11

    CrossRefPubMedWeb of Science
19. ↵
    Burger PC. Malignant astrocytic neoplasms: classification, pathologic anatomy, and response to treatment. Semin Oncol 1986;13:16–26

    PubMed
20. ↵
    Kleihues P, Cavanee P. WHO Classification of Tumors: Pathology and Genetic of Tumours of the Nervous System. Lyon, France: IARC Press;2000
21. ↵
    Lev MH, Ozsunar Y, Henson JW, et al. Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas [corrected]. AJNR Am J Neuroradiol 2004;25:214–21

    Abstract/FREE Full Text
22. ↵
    Cha S, Yang L, Johnson G, et al. Comparison of microvascular permeability measurements, K(trans), determined with conventional steady-state T1-weighted and first-pass T2*-weighted MR imaging methods in gliomas and meningiomas. AJNR Am J Neuroradiol 2006;27:409–17

    Abstract/FREE Full Text
23. ↵
    Poussaint TY, Rodriguez D. Advanced neuroimaging of pediatric brain tumors: MR diffusion, MR perfusion, and MR spectroscopy. Neuroimaging Clin N Am 2006;16:169–92, ix

    CrossRefPubMed
24. ↵
    Lu H, Golay X, Pekar JJ, et al. Functional magnetic resonance imaging based on changes in vascular space occupancy. Magn Reson Med 2003;50:263–74

    CrossRefPubMedWeb of Science
25. ↵
    Herscovitch P, Raichle ME. What is the correct value for the brain-blood partition coefficient for water? J Cereb Blood Flow Metab 1985;5:65–69

    PubMedWeb of Science
26. ↵
    Wetzel SG, Cha S, Johnson G, et al. Relative cerebral blood volume measurements in intracranial mass lesions: interobserver and intraobserver reproducibility study. Radiology 2002;224:797–803

    CrossRefPubMedWeb of Science
27. ↵
    Tofts PS, Kermode AG. Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts. Magn Reson Med 1991;17:357–67

    CrossRefPubMedWeb of Science
28. ↵
    Tofts PS, Brix G, Buckley DL, et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 1999;10:223–32

    CrossRefPubMedWeb of Science
29. ↵
    Ostergaard L, Sorensen AG, Kwong KK, et al. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part II: experimental comparison and preliminary results. Magn Reson Med 1996;36:726–36

    CrossRefPubMedWeb of Science
30. ↵
    Roberts HC, Roberts TP, Ley S, et al. Quantitative estimation of microvascular permeability in human brain tumors: correlation of dynamic Gd-DTPA-enhanced MR imaging with histopathologic grading. Acad Radiol 2002;9 (suppl 1):S151–55

    CrossRefPubMed
31. ↵
    Provenzale JM, Wang GR, Brenner T, et al. Comparison of permeability in high-grade and low-grade brain tumors using dynamic susceptibility contrast MR imaging. AJR Am J Roentgenol 2002;178:711–16

    CrossRefPubMedWeb of Science
32. ↵
    Rydland J, BjOrnerud A, Haugen O, et al. New intravascular contrast agent applied to dynamic contrast enhanced MR imaging of human breast cancer. Acta Radiol 2003;44:275–83

    CrossRefPubMedWeb of Science
33. ↵
    Tomita M. Significance of cerebral blood volume. In: Tomita M, Sawada T, Naritomi H, eds. Cerebral Hyperemia and Ischemia: From the Standpoint of Cerebral Blood Volume. New York: Elsevier Science Publisher;1988 :3–30
34. ↵
    Kuschinsky W. Regulation of cerebral blood flow: an overview. In: Mraovitch S, Sercombe R, eds. Neurophysiological Basis of Cerebral Blood Flow Control: An Introduction. London: Johns Libbey & Company Ltd;1996 :245–62
35. ↵
    Lev MH, Vedolin L. Permeability versus cerebral blood volume measurement in brain tumor evaluation: comparative clinical value and advice to authors. AJNR Am J Neuroradiol 2006;27:418–19

    FREE Full Text
36. ↵
    Ringertz N. Grading of gliomas. Acta Pathol Microbiol Scand 1950;27:51–64

    PubMedWeb of Science